Skip to main content
Erschienen in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01.12.2019 | Research

Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature

verfasst von: Huakun Shangguan, Chang Su, Qian Ouyang, Bingyan Cao, Jian Wang, Chunxiu Gong, Ruimin Chen

Erschienen in: Orphanet Journal of Rare Diseases | Ausgabe 1/2019

Abstract

Objective

This study describes 5 novel variants of 7 KMT2D/KDM6A gene and summarizes the clinical manifestations and the mutational spectrum of 47 Chinese Kabuki syndrome (KS) patients.

Methods

Blood samples were collected for whole-exome sequencing (WES) for 7 patients and their parents if available. Phenotypic and genotypic spectra of 40 previously published unrelated Chinese KS patients were summarized.

Result

Genetic sequencing identified six KMT2D variants (c.3926delC, c.5845delC, c.6595delT, c.12630delG, c.16294C > T, and c.16442delG) and one KDM6A variant (c.2668-2671del). Of them, 4 variants (c.3926delC, c.5845delC, c.12630delG, and c.16442delG) in KMT2D gene and the variant (c.2668-2671del) in KDM6A gene were novel. Combining with previously published Chinese KS cases, the patients presented with five cardinal manifestations including facial dysmorphism, intellectual disability, growth retardation, fingertip pads and skeletal abnormalities. In addition, 29.5% (5/17) patients had brain abnormalities, such as hydrocephalus, cerebellar vermis dysplasia, thin pituitary and white matter myelination delay, corpus callosum hypoplasia and Dandy-Walker malformation.

Conclusion

In this report, five novel variants in KMT2D/KDM6A genes are described. A subset of Chinese KS patients presented with brain abnormalities that were not previously reported. Our study expands the mutational and phenotypic spectra of KS.
Hinweise
Huakun Shangguan and Chang Su contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ACMG/AMP
American College of Medical Genetics and Genomics and the Association for Molecular Pathology
KDM6A
lysine (K)-specific methylase 6A
KMT2D
lysine (K)-specific methyltransferase 2D
KS
Kabuki syndrome
WES
whole-exome sequencing

Introduction

Kabuki syndrome (KS, OMIM#147920) is a rare syndrome with multiple congenital anomalies. It was first reported by Japanese researchers Kuroki and Niikawa [1, 2]. KS is a heterogeneous condition, two causative genes having been identified so far. The causative gene of KS was identified in 2010 when Bögershausen et al. [3] reported de novo heterozygous variants in KMT2D gene, which is located on chromosome 12q13. Later, in 2012, variants in the KDM6A gene, which is located on chromosome Xp11.23, were identified as another causative gene for KS [4].
Consistent features of KS included distinctive facial dysmorphism (long palpebral fissures, depressed nasal tip and large ears), short stature, intellectual disability, skeletal abnormalities and dermatoglypic abnormalities. Other recurrent features such as congenital cardiac anomalies, ureter malformation and hip joint dislocation had been reported in non-Chinese KS patients [5]. In addition, uncommon features had also been reported. Topcu et al. reported perisylvian cortical dysplasia in a KS patient from Turkey [6]. However, there is little information about brain abnormalities in KS patients.
Herein, we analyzed 7 patients, and identified 7 deleterious KMT2D/KDM6A variants including 6 truncating and 1 missense variants. Of them, 5 variants were novel. To date, 40 sporadic Chinese KS patients had been reported [715]. We evaluated the phenotype spectra of all Chinese KS patients and paid particular attention to the brain abnormalities among a total of 47 unrelated Chinese KS patients.

Subjects and methods

Subjects

Seven patients with clinical presentation of Kabuki syndrome were enrolled from Fuzhou Children’s Hospital of Fujian and Beijing Children’s Hospital, China. This study was approved by the Ethics Committee of Fuzhou Children’s Hospital of Fujian, and written informed consents were obtained from the participants’ legal guardians.

Whole-exome sequencing and variants interpretation

Genomic DNA was extracted from peripheral blood leukocytes of each patient. Blood samples from the parents were also collected if available. The whole-exome sequencing (WES) was performed at Shanghai Children’s Medical Center and MyGenostics, Beijing, China. An adaptor-ligated library was prepared using SureSelect Human All Exon Kit (Agilent Technologies, Santa Clara, America) according to the manufacturer’s protocol. Target regions were sequenced on an Illumina Hiseq X Ten System (Illumina, San Diego, America). Paired end reads were aligned to the GRCh37/hg19 human reference sequence. BAM files were generated by Picard and sequence variants were called by Genome Analysis Toolkit (GATK) Haplotype Caller.
Variants were annotated by TGex and putative pathogenic variants detected in the patients by WES were validated by Sanger sequencing. Variants were classified following the ACMG/AMP standards and guidelines [16].

Results

Clinical manifestations of seven Chinese patients with KS

We enrolled 7 patients with clinical diagnosis of KS (three males and four females). The age of initial diagnosis ranged from 7 days to 3.2 years. These patients exhibited a diverse phenotype. The clinical features of the seven Chinese patients are listed in Table 1. The main characteristics were as following: facial dysmorphism (n = 7), cardiac abnormalities (n = 6), intellectual disability (n = 5), short stature (n = 4), skeletal abnormalities (n = 3), hearing impairment (n = 3) and dermatoglypic abnormalities (n = 2).
Table 1
Phenotypic summary of Chinese KS patients
Patient
1
2
3
4
5
6
7
Literature (N = 40)
Chinese cohort (N = 47)
Non-Chinese cohort (N = 86) (Ref. 17)
Gender
Female
Female
Male
Female
Male
Male
Female
   
Age of diagnosis
1.3 yrs
11 Months
5 Months
7d
7 yrs
2.6 Months
3.2 yrs
   
Growth
 Short stature
+
+
+
+
23
57.4%
57%
Neurological abnormalities
 Intellectual disability
+
+
NA
+
+
+
32
80.4%
90%
 Seizures
4
8.5%
15%
 Cerebellar vermis dysplasia
1
2.1%
 
 Corpus callosum hypoplasia
1
2.1%
 
 Dany-Walker malformation
1
2.1%
 
 Thinning of pituitary
+
0
2.1%
 
 Delay myelination of cerebral
+
0
2.1%
 
 Hydrocephalus
1
2.1%
 
Craniofacial features
 Microcephaly
+
+
3
10.6%
41%
 Micrognathia
3
6.3%
39%
 High forehead and hairline
+
0
2.1%
 
 Low hairline
+
2
6.3%
 
 Hypertelorism
+
+
8
21.2%
 
 Epicanthus
+
8
19.1%
 
 Long palpebral fissures
+
+
+
15
38.2%
99%
 Strabismus
1
2.1%
37%
 Eversion of lateral third of lower eyelids
+
+
+
+
14
38.2%
87%
 Long eyelashes
+
+
9
23.9%
 
 Arched eyebrows
+
+
2
8.7%
 
 Sparse eyebrows
+
+
18
42.5%
 
 Depressed nasal tip
+
+
+
+
29
70.2%
80%
 Wide nasal bridge
+
+
+
7
21.9%
 
 A displastic ear
+
3
8.7%
 
 Large ears
+
+
+
29
68.0%
79%
 High-arched/cleft palate
+
+
+
24
57.4%
66%
 Thin upper vermillion
+
+
+
2
10.6%
76%
 Abnormal dentition
5
10.6%
51%
Congenital heart defect
+
+
+
+
+
+
14
42.6%
42%
 Aortic coartation
+
1
4.3%
 
 Atrial septal defect
+
+
+
+
6
21.7%
 
 Ventricular septal defects
+
+
+
+
6
21.7%
 
 Patent ductus arteriosus
+
+
1
6.5%
 
 Patent foramen ovale
+
+
+
+
+
5
21.7%
 
 Aortic arch dysplasia
+
0
2.2%
 
Internal organ problem
 Feeding difficulties
+
3
8.5%
 
 Anal atresia
+
3
8.5%
 
 Bilateral inguinal hernia
2
4.2%
 
 Splenomegaly
+
1
4.2%
 
 Cryptorchidism
1
2.%
 
 Hearing impairment
+
+
+
13
34.0%
25%
 Otitis media
+
12
27.6%
 
 Cholesteatoma
+
2
6.4%
 
 Cochlear dysplasia
+
0
2.1%
 
 Renal/ureter malformation
+
+
+
2
10.6%
40%
Musculoskeletal features
 Hip joint dislocation
+
+
9
23.4%
26%
 Right diaphyseal femoral fracture
+
0
2.1%
 
 Fifth finger clinodactyly
+
22
48.9%
84%
 Absent palmer transverse crease
+
5
12.7%
 
 Fingertip pads
+
24
53.2%
89%
Endocrine
 Hypoglycemia
+
+
2
8.5%
7–8%
 Early breast development
 
+
1
4.2%
28%

Pathogenic variants in KMT2D and KDM6A

By WES, we identified six variants (c.3926delC/p.P1309Qfs*21, c.5845delC/p.Q1949Sfs*98, c.6595delT/p.Y2199Ifs*65, c.12630delG/p.Q4210fs*5, c.16294C > T/p.R5432W and c.16442delG/p.C5481Lfs*6) in exon 12, 27, 31, 39, 51 and 52 of KMT2D gene (NM_003482.3), respectively, and one variant (c.2668-2671del) in exon 18 of KDM6A gene (NM_021140.3). The variants identified (c.5845delC, c.2668-2671del and c.12630delG) in 3 patients were confirmed by Sanger sequencing, and they were absent from their parents. The other 4 patients’ parental DNA were not available for genetic testing. Four variants (c.3926delC, c.5845delC, c.12630delG and c.16442delG in KMT2D gene, and the variant in KDM6A gene) were novel. Those 6 frameshift variants were predicted to lead to nonsense-mediated decay of mRNA. These null variants can all be classified as pathogenic according to the ACMG/AMP standards and guidelines (c.3926delC, c.5845delC, c.6595delT, c.12630delG, c.16442delG and c.2668-2671del). The remaining missense variant c.16294C > T; p.R5432W in KMT2D gene has been previously reported [17]. The variant c.16294C > T; p.R5432W was predicted to be deleterious by multiple in silico software, including SIFT (damaging), PolyPhen-2 (probably damaging), MutationTaster (disease causing), PROVEAN (deleterious), and CADD (damaging). Therefore, it can be considered to be likely pathogenic.

Phenotypic spectrum of 47 Chinese KS patients

Forty Chinese patients had been previously reported with KMT2D/KDM6A mutations. With the new 7 patients adding, we summarized the phenotypic features of a total of 47 Chinese KS patients (Table 1). The major clinical signs were as following: facial dysmorphisms (47/47; 100%), intellectual disability (36/45; 80%), short stature (27/47; 57.4%) patients, fingertip pads (25/47; 53.1%), finger clinodactyly (23/47; 48.9%), 5th finger clinodactyly (23/47; 48.9%), congenital cardiac anomalies (20/47; 42.5%) and hip joint dislocation (11/47; 23.4%). Additionally, brain imaging datasets were available for 17 patients and five patients (5/17, 29.4%) exhibited disparate brain anomalies.

Discussion

The genotypic spectrum of 47 Chinese KS patients (23 females, 24 males, 3 are sibs), including 42 KMT2D variants and 3 KDM6A variants were summarized (Table 2). Of the 42 KMT2D variants, there are 1 splicing, 1 non-frameshift indel, 10 nonsense, 13 frameshift and 17 missense variants. All of the nonsense and frameshift variants were categorized as pathogenic because the protein structure was significantly altered. We used silico prediction models including PolyPhen-2, PROVEAN, MutationTaster to analyze the missense variants. Two missense variants (c.7130C > T and c.11638C > A) are predicted to be benign, neutral or polymorphism by at least two of the three silico prediction models. The pathogenicity of the two variants (c.7130C > T and c.11638C > A) was inconclusive and could potentially be non-pathogenic according ACMG/AMP standards and guidelines. The p.R5432W variant was most common, observed in 3 unrelated patients (P2, P28 and P46), which may be a hot spot for KMT2D gene variation in Chinese Patients. Thirty four KMT2D variants and 3 KDM6A variants were confirmed by Sanger sequencing. Of them, 2 variants (c.16273C > A and c.7130 C > T) in KMT2D gene were inherited from their respective biological father, and 1 variant (c.335-1G > T) in KDM6A were inherited from mother, whereas the other 34 variants were de novo.
Table 2
Genotypic summary of Chinese KS patients
Case ID
Literature
Genes involve
Mutation
Preticted protein changes
Type of mutation
Inheritance
Exon
Pathogenic classification
1
This study
KMT2D
c.5845delC
p.Q1949Sfs*98
Frameshift del
De novo
27
Pathogenic
2
KMT2D
c.16294C > T
p.R5432W
Missense
NA
51
Likely Pathogenic
3
KDM6A
c.2668-2671del
p.N891Vfs*27
Frameshift del
De novo
18
Pathogenic
4
KMT2D
c.6595delT
p.Y2199Ifs*65
Frameshift del
NA
31
Pathogenic
5
KMT2D
c.16442delG
p.C5481Lfs*6
Frameshift del
NA
52
Pathogenic
6
KMT2D
c.3926delC
p.P1309Qfs*21
Frameshift del
NA
12
Pathogenic
7
KMT2D
c.12630delG
p.Q4210fs*5
Frameshift del
De novo
39
Pathogenic
8
[7] Liu S, et al. BMC Med Genet. 2015, 16:26.
KMT2D
c.12199C > T
p.P4067Sr
Missense
De novo
39
Likely Pathogenic
c.16295G > A
p.R5432Q
Missense
De novo
51
Likely Pathogenic
9
KMT2D
c.4664C > T
p.S1555F
Missense
De novo
17
Likely Pathogenic
10
KMT2D
c.8639 T > C
p.L2880P
Missense
De novo
34
Likely Pathogenic
11
KMT2D
c.3095delT
p.L1032Rfs24X
Frameshift del
NA
11
Pathogenic
12
KMT2D
c.96C > G
p.D32E
Missense
De novo
2
Likely Pathogenic
13
KMT2D
c.4395dupC
p.K1466Qfs25X
Frameshift del
NA
15
Pathogenic
14
KMT2D
c.11638C > Aa
p.L3880 M
Missense
NA
39
Uncertain significance
15
KMT2D
c.4140 T > A
p.C1370X
Nonsense
NA
14
Pathogenic
c.11718-11723delGCAACA
 
Non-Frameshift indel
NA
39
Likely Pathogenic
16
[8] Yang P, et al. Am J Med Genet A. 2016, 170 (6): 1613–21.
KDM6A
exon1-2del
 
Frameshift del
De novo
 
Pathogenic
17
[9] Wu BB, et al. Chin J Evid Based Pediatr. 2017, 12 (2):135–9.
KMT2D
c.12697C > T
p.Q4233X
Nonsense
De novo
39
Pathogenic
c.12696C > T
p.Q4232H
Missense
De novo
39
Pathogenic
18
KMT2D
c.3495delC
p.P1165Lfs*47
Frameshift del
De novo
11
Pathogenic
19
KMT2D
c.10881delT
p.L3627Rfs*31
Frameshift del
De novo
39
Pathogenic
20
KMT2D
c.16498C > T
p.R5500W
Missense
NA
53
Likely Pathogenic
21
KMT2D
c.12560G > A
p.G4187E
Missense
NA
39
Likely Pathogenic
22
KMT2D
c.16273G > A
p.E5425K
Missense
NA
51
Likely Pathogenic
23
[10] JUN LU, et al. MOLECULAR MEDICINE REPORTS. 2016, 14: 3641–3645.
KMT2D
c.4485C > A
p.Y1495S
Missense
De novo
16
Pathogenic
24
[11] Chengqi Xin, BMC Medical Genetics. 2018, 19:31
KMT2D
c.5235delA
p.A1746Lfs*39
Frameshift del
De novo
22
Pathogenic
25
KMT2D
c.7048G > A
p.Q2350*
Frameshift del
De novo
31
Pathogenic
26
[12] Ju-Li Lin, et al. Clinical Genetics, 2015, 88 (3): 255–260.
KMT2D
c.12307C > T
p.Q4013X
Nonsense
De novo
38
Pathogenic
27
KMT2D
c.3754C > T
p.R1252X
Nonsense
De novo
11
Pathogenic
28
KMT2D
c.16294C > T
p.R5432W
Nonsense
De novo
51
Likely Pathogenic
29
KMT2D
c.5993A > G
p.Y1998C
Missense
De novo
28
Likely
Pathogenic
30
KMT2D
c.16273G > A
p. E5425K
Missense
Father
51
Likely Pathogenic
31
KMT2D
c.16273G > A
p. E5425K
Missense
Father
51
Likely Pathogenic
32
KMT2D
c.16273G > A
p. E5425K
Missense
Father
51
Likely Pathogenic
33
KMT2D
c.8743C > T
p.R2915X
Nonsense
De novo
34
Pathogenic
34
KMT2D
c.5269C > T
p.R1757X
Nonsense
De novo
22
Pathogenic
35
KMT2D
c.16273G > A
p.E5425K
Missense
De novo
51
Likely
Pathogenic
36
KMT2D
c.7650-1delCT
p.P2550Rfs2604X
Frameshift del
De novo
31
Pathogenic
37
KMT2D
c.16135C > T
p.Q5379X
Nonsense
De novo
51
Pathogenic
38
KMT2D
c.15326G > T
p.C5109F
Missense
De novo
48
Pathogenic
39
KMT2D
c.16498C > T
p.R5500W
Missense
De novo
53
Pathogenic
40
[13] LI Jieling, ea. al. J Clin Pediatr. 2018, 1 (36): 53–56.
KMT2D
c.7130C > Ta
p.P2377L
Missense
Father
31
Uncertain significance
41
KMT2D
IVS9 + 2 T > G
 
Splice mutation
De novo
 
Pathogenic
42
[14] Wang Hongmei, et al. Chin J Pediatr. 2018, 56 (11): 846–849.
KMT2D
c.11770C > T
p.Q3924X
Nonsense
De novo
39
Pathogenic
43
KMT2D
c.13033A > T
p.K4345X
Nonsense
De novo
39
Pathogenic
44
KMT2D
c.1763C > G
p.S588X
Nonsense
De novo
10
Pathogenic
45
KMT2D
c.5848delT
p.S1950Pfs*97
Frameshift
De novo
27
Pathogenic
46
KMT2D
c.16294C > T
p.R5432W
Missense
De novo
51
Likely
Pathogenic
47
[15] Guo Z,et al. BMC Med. Genet. 2018, 12 03;19 (1).
KDM6A
c.335-1G > T
 
Splice site mutation
mother
 
Likely Pathogenic
aNo sufficient evidence supporting it’s pathogenicity *Denotes a frameshift change as the first affected amino acid
A phenotypic comparison between the 47 Chinese patients and a cohort of 86 patients from other populations was showed in Table 1. It was reported that the long palpebral fissures were observed in 99% of non-Chinese KS patients, and the eversion of lateral third of lower eyelids 87% [17]. The Chinese patients showed a significantly lower frequency (38.2% for both features). While a lack of clinical acuity in recognizing these features by clinicians could account for some differences, we think it may more likely reflecting the ethnicity difference in feature presentations. Additionally, The Chinese patients had higher frequency of hearing impairment but lower frequency of microcephaly, micrognathia, strabismus, abnormal dentition, fifth finger clinodactyly and fingertip pads. The frequencies of other phenotypes including short stature, intellectual disability, cardiac defects, large eras, hypoglycemia and high-arched/cleft palate were consistent with previously reported [17].
KMT2D/KDM6A affects genes and biological processes globally. The clinical consequence of KMT2D/KDM6A gene mutations also seems to have a global effect on development and growth, both craniofacial, cardiac, neural and musculoskeletal (presented with short stature) tissue [18]. Across the board, the Chinese KS patients had typical facial features. These dysmorphic features included long palpebral fissures, depressed nasal tip and large ears (most prominent from the profile), similar to the KS patients from other ethnicities, indicating a consistent and highly penetrant facial dysphormic profile across populations.
Thirty-one Chinese patients presented with intellectual disability, most were mildly affected. Mehmet et al. [19] reported one and Parisi et al. [20] reported three KS patients with autism spectrum disorder, yet none of the Chinese KS patients exhibited autistic features or significant behavioral issues. Various structural brain anomalies had been infrequently described in KS patients. Topcu et al. reported perisylvian cortical dysplasia [6]. Cedrik et al. reported two patients presented with holoprosencephaly [21]. Furthermore, based on MRI, significantly decreased grey matter volume in the bilateral hippocampus and dentate gyrus have been described in KS patients [22]. We found the brain abnormalities including thinning of pituitary and myelination of cerebral white matter in Chinese KS patients, which were not previously reported in KS patients. We also found that hydrocephalus, corpus callosum hypoplasia and Dandy-Walker malformation which had been reported previously both in Chinese patients and other populations [7, 15]. In addition, cerebellar vermis dysplasia was initially reported in Chinese patients [11]. These observations suggested a strong association between various brain abnormalities and KS. Further study is needed to explore the clinical consequences of these brain abnormalities.

Conclusions

We described five novel variants that are causal for the seven KS Chinese patients, and confirmed that the Chinese KS presented with typical clinical phenotypes as previously reported in non-Chinese patients, but of variable feature prevalence. We also pointed out that brain structural abnormalities including thinning of pituitary and delay myelination of cerebral white matter may be part of KS phenotype that warrant further investigation.

Acknowledgments

The authors offer their sincere thanks to all the participants and their families who participated in the clinical trial.
This study was approved by the Ethics Committee of Fuzhou Children’s Hospital of Fujian, and written informed consents were obtained from the participants’ legal guardians.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Niikawa N, Matsuura N, Fukushima Y, et al. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99(4):565–9.CrossRef Niikawa N, Matsuura N, Fukushima Y, et al. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99(4):565–9.CrossRef
2.
Zurück zum Zitat Kuroki Y, Suzuki Y, Chyo H, et al. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. Pediatr. 1981;99:570–3.CrossRef Kuroki Y, Suzuki Y, Chyo H, et al. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. Pediatr. 1981;99:570–3.CrossRef
3.
Zurück zum Zitat Bogershausen Y, Alanay N, Kiper YS, et al. A mutation screen in patients with kabuki syndrome. Hum Genet. 2011;130:715–24.CrossRef Bogershausen Y, Alanay N, Kiper YS, et al. A mutation screen in patients with kabuki syndrome. Hum Genet. 2011;130:715–24.CrossRef
4.
Zurück zum Zitat Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with kabuki syndrome. Am J Hum Genet. 2012;90:119–24.CrossRef Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with kabuki syndrome. Am J Hum Genet. 2012;90:119–24.CrossRef
5.
Zurück zum Zitat Digilio MC, Gnazzo M, Lepri F, Dentici ML, et al. Congenital heart defects in molecularly proven kabuki syndrome patients. Am J Med Genet A. 2017;173(11):2912–22.CrossRef Digilio MC, Gnazzo M, Lepri F, Dentici ML, et al. Congenital heart defects in molecularly proven kabuki syndrome patients. Am J Med Genet A. 2017;173(11):2912–22.CrossRef
6.
Zurück zum Zitat Topcu Y, Bayram E, Karaoglu P, Yis U, Kurul SH. Kabuki syndrome and perisylvian cortical dysplasia in a Turkish girl. J Pediatr Neurosci. 2013;8(3):259–60.CrossRef Topcu Y, Bayram E, Karaoglu P, Yis U, Kurul SH. Kabuki syndrome and perisylvian cortical dysplasia in a Turkish girl. J Pediatr Neurosci. 2013;8(3):259–60.CrossRef
7.
Zurück zum Zitat Liu S, Hong X, Shen C, Shi Q, et al. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Med Genet. 2015;16:26.CrossRef Liu S, Hong X, Shen C, Shi Q, et al. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Med Genet. 2015;16:26.CrossRef
8.
Zurück zum Zitat Yang P, Tan H, Xia Y, Yu Q, et al. De novo exonic deletion of KDM6A in a Chinese girl with kabuki syndrome: a case report and brief literature review. Am J Med Genet A. 2016;170(6):1613–21.CrossRef Yang P, Tan H, Xia Y, Yu Q, et al. De novo exonic deletion of KDM6A in a Chinese girl with kabuki syndrome: a case report and brief literature review. Am J Med Genet A. 2016;170(6):1613–21.CrossRef
9.
Zurück zum Zitat Wu BB, Su YJ, Wang HJ, et al. Report of 6 kabuki syndrome cases caused by KMT2D gene mutation and literature review. Chin J Evid Based Pediatr. 2017;12(2):135–9. Wu BB, Su YJ, Wang HJ, et al. Report of 6 kabuki syndrome cases caused by KMT2D gene mutation and literature review. Chin J Evid Based Pediatr. 2017;12(2):135–9.
10.
Zurück zum Zitat Jun L, Guiling M, Ling Y, et al. A novel KMT2D mutation resulting in kabuki syndrome: a case report. Mol Med Rep. 2016;14:3641–5.CrossRef Jun L, Guiling M, Ling Y, et al. A novel KMT2D mutation resulting in kabuki syndrome: a case report. Mol Med Rep. 2016;14:3641–5.CrossRef
11.
Zurück zum Zitat Xin C, Wang C, Wang Y, et al. Identification of novel KMT2D mutations in two Chinese children with kabuki syndrome: a case report and systematic literature review. BMC Med Genet. 2018;19:31.CrossRef Xin C, Wang C, Wang Y, et al. Identification of novel KMT2D mutations in two Chinese children with kabuki syndrome: a case report and systematic literature review. BMC Med Genet. 2018;19:31.CrossRef
12.
Zurück zum Zitat Lin J-L, Lee W-I, Huang J-L, et al. Immunologic assessment and KMT2D mutation detection in kabuki syndrome. Clin Genet. 2015;88(3):255–60.CrossRef Lin J-L, Lee W-I, Huang J-L, et al. Immunologic assessment and KMT2D mutation detection in kabuki syndrome. Clin Genet. 2015;88(3):255–60.CrossRef
13.
Zurück zum Zitat Jieling L, Jie C. Kabuki syndrome: two case report. J Clin Pediatr Dent. 2018;1(36):53–6. Jieling L, Jie C. Kabuki syndrome: two case report. J Clin Pediatr Dent. 2018;1(36):53–6.
14.
Zurück zum Zitat Wang H, Wang X, Wu H, et al. Clinical and laboratory characteristics and genetic diagnosis of kabuki syndrome. Chin J Pediatr. 2018;56(11):846–9. Wang H, Wang X, Wu H, et al. Clinical and laboratory characteristics and genetic diagnosis of kabuki syndrome. Chin J Pediatr. 2018;56(11):846–9.
15.
Zurück zum Zitat Guo Z, Liu F, Li HJ, et al. Novel KDM6A splice-site mutation in kabuki syndrome with congenital hydrocephalus: a case report. BMC Med Genet. 2018;19(1):0724–8. Guo Z, Liu F, Li HJ, et al. Novel KDM6A splice-site mutation in kabuki syndrome with congenital hydrocephalus: a case report. BMC Med Genet. 2018;19(1):0724–8.
16.
Zurück zum Zitat Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:668–88.CrossRef Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:668–88.CrossRef
17.
Zurück zum Zitat Makrythanasis P, van Bon BW, Steehouwer M, Rodríguez-Santiago B, et al. MLL2 mutation detection in 86 patients with kabuki syndrome: a genotype–phenotype study. Clin Genet. 2013;6(84):539–45.CrossRef Makrythanasis P, van Bon BW, Steehouwer M, Rodríguez-Santiago B, et al. MLL2 mutation detection in 86 patients with kabuki syndrome: a genotype–phenotype study. Clin Genet. 2013;6(84):539–45.CrossRef
18.
Zurück zum Zitat Van Laarhoven PM, Neitzel LR, Quintana AM, Geiger EA, et al. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015;24(15):4443–53.CrossRef Van Laarhoven PM, Neitzel LR, Quintana AM, Geiger EA, et al. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015;24(15):4443–53.CrossRef
19.
Zurück zum Zitat Sertçelik M, Uğur Ç, Şahin Aközel A, Gürkan CK, et al. A child with kabuki syndrome and autism Spectrum disorder. Noro Psikiyatr Ars. 2016;53(3):280–2.CrossRef Sertçelik M, Uğur Ç, Şahin Aközel A, Gürkan CK, et al. A child with kabuki syndrome and autism Spectrum disorder. Noro Psikiyatr Ars. 2016;53(3):280–2.CrossRef
20.
Zurück zum Zitat Parisi L, Di Filippo T, Roccella M, et al. Autism spectrum disorder in kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases. Minerva Pediatr. 2015;67(4):369–75.PubMed Parisi L, Di Filippo T, Roccella M, et al. Autism spectrum disorder in kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases. Minerva Pediatr. 2015;67(4):369–75.PubMed
21.
Zurück zum Zitat Tekendo-Ngongang C, Kruszka P, Martinez AF, Muenke M, et al. Novel heterozygous variants in KMT2D associated with holoprosencephaly. Clin Genet. 2019;96(3):1–5.CrossRef Tekendo-Ngongang C, Kruszka P, Martinez AF, Muenke M, et al. Novel heterozygous variants in KMT2D associated with holoprosencephaly. Clin Genet. 2019;96(3):1–5.CrossRef
22.
Zurück zum Zitat Boisgontier J, Tacchella JM, Lemaître H, Lehman N, et al. Anatomical and functional abnormalities on MRI in kabuki syndrome. Neuroimage Clin. 2019;21:0802–8.CrossRef Boisgontier J, Tacchella JM, Lemaître H, Lehman N, et al. Anatomical and functional abnormalities on MRI in kabuki syndrome. Neuroimage Clin. 2019;21:0802–8.CrossRef
Metadaten
Titel
Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature
verfasst von
Huakun Shangguan
Chang Su
Qian Ouyang
Bingyan Cao
Jian Wang
Chunxiu Gong
Ruimin Chen
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Orphanet Journal of Rare Diseases / Ausgabe 1/2019
Elektronische ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1219-x

Weitere Artikel der Ausgabe 1/2019

Orphanet Journal of Rare Diseases 1/2019 Zur Ausgabe